Biogen Pharma

Market Cap: Micro Cap
Industry: Non Banking Financial Company (NBFC)
ISIN: INE703D01023
NSEID:
BSEID: 531752
View on BSE

INR

0.37

0.00 (0.00%)

BSENSE

May 21

BSE+NSE Vol: 30.61 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kalyan Capitals

Ajcon Global

Cont. Securities

Futuristic Solu

Lak. Fin. & Indl

Relic Tech.

Biogen Pharma

Key Corp

Madhusudan Sec.

Pan India Corpor

Bervin Invest.

Why is Biogen Pharmachem Industries Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.86
The company has been able to generate a Return on Equity (avg) of 2.22% signifying low profitability per unit of shareholders funds

Flat results in Mar 26

PBT LESS OI(Q) At Rs -0.36 cr has Fallen at -130.51%

Risky - Negative EBITDA

The company has recorded a negative EBITDA of Rs. -0.49 cr
Over the past year, while the stock has generated a return of -61.86%, its profits have risen by 124% ; the PEG ratio of the company is 0.1
The stock is trading risky as compared to its average historical valuations

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biogen Pharma for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biogen Pharma

-61.86%

-1.35

45.98%

Sensex

-7.99%

-0.58

12.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.12%

EBIT Growth (5y)

-12.60%

EBIT to Interest (avg)

0.86

Debt to EBITDA (avg)

2.60

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.02

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

0.43%

ROE (avg)

2.22%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.39

EV to EBIT

-38.59

EV to EBITDA

-38.59

EV to Capital Employed

0.39

EV to Sales

34.46

PEG Ratio

0.14

Dividend Yield

ROCE (Latest)

0.05%

ROE (Latest)

0.96%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-3What is not working for the Company

PBT LESS OI(Q)

At Rs -0.36 cr has Fallen at -130.51%

Loading Valuation Snapshot...

Here's what is not working for Biogen Pharma

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -0.36 cr has Fallen at -130.51%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)